Profile Photo

Dr. Kaushal Anand MBBS , MS (General Surgery), G.I. Surgery (SGPGIMS)

Shailya Hospital, Ahmedabad

25 Years Experience

Dr. Kaushal Anand – Robotic G.I., HPB & Abdominal Cancer Surgeon

MBBS, MS (General Surgery), G.I. Surgery (SGPGIMS), HPB Surgery (Fukuoka, Japan) FIAGES, FICS, FMAS

Professional Summary

Dr. Kaushal Anand (often referred to as Dr. Anand Kaushal) is a distinguished Robotic G.I., HPB (HepatoPancreatoBiliary) & Abdominal Cancer Surgeon and Director at Shailya Hospital, Ahmedabad. With over 2526 years of surgical experience and focused expertise in gastrointestinal, liver, pancreatic, biliary and abdominal cancer surgery, he is widely regarded as one of Ahmedabads leading surgical gastroenterologists.

Trained at premier Indian and international centers—including SGPGIMS Lucknow, Kurume University in Fukuoka (Japan) and Asan Medical Centre in Seoul (world leader in liver transplantation)—Dr. Anand combines highend technical skill with a strong clinician first philosophy. He has performed several thousand complex G.I. and HPB procedures and has been recognized as “Best Surgical Gastroenterologist, HPB & Cancer Surgeon of the Year – 2021.”

Hospital Affiliations

Shailya Hospital, Ahmedabad

·       Director & Chief Surgical Gastroenterologist

·       Robotic G.I., HPB & Abdominal Cancer Surgeon

Key Features at Shailya Hospital:

·       Superspecialized G.I. & HPB surgery center

·       20+ years of institutional experience with thousands of complex abdominal surgeries

·       Advanced operating theaters supporting laparoscopic and robotic surgery

·       Dedicated liver & pancreatic clinic for focused HPB care

·       Multidisciplinary tumor board approach for G.I. and HPB cancers

SuperSpeciality & Fellowships

·       G.I. Surgery (Surgical Gastroenterology) – SGPGIMS, Lucknow (3year structured training in G.I. & liver transplantation)

·       Fellow in G.I. & Minimal Access Surgery – Sterling Hospital, Ahmedabad (2003–2005)

·       HPB Surgery Fellowship – Kurume University, Fukuoka, Japan, under renowned liver surgeon Dr. Koji Okuda – advanced and complex liver cancer and HPB procedures

·       Liver Transplantation Fellowship – Asan Medical Centre, Seoul, South Korea, under Prof. SungGyu Lee (worlds leading liver transplant center)

 

Areas of Specialization

1. Gastrointestinal (G.I.) Cancer Surgery

·       Esophageal and gastric (stomach) cancers

·       Small and large bowel (colon and rectal) cancers

·       GIST and other small bowel tumors

·       Complex abdominal and retroperitoneal tumors

·       Robotic and laparoscopic oncologic resections for improved precision and recovery

2. HPB (HepatoPancreatoBiliary) Surgery

·       Liver:

o   Hepatocellular carcinoma (HCC) resections

o   Metastatic liver tumors (e.g., colorectal liver metastases)

o   Complex segmental and extended liver resections

o   Benign liver tumors, cysts and hemangiomas

·       Pancreas:

o   Pancreatic head cancers (including Whipple’s pancreaticoduodenectomy)

o   Pancreatic body/tail tumors and distal pancreatectomy

o   Acute and chronic pancreatitis surgeries

o   Pancreatic cystic neoplasms and pseudocysts

·       Biliary Tract & Gallbladder:

o   Gallbladder cancer and complex cholecystectomy

o   Choledochal cysts and bile duct strictures

o   Perihilar and distal cholangiocarcinoma resections

o   Bile duct injury repair and biliary reconstruction

3. Robotic & Advanced Laparoscopic G.I. Surgery

·       Robotic colorectal cancer surgery

·       Robotic liver and pancreatic procedures (selected cases)

·       Advanced laparoscopic resections for colon, rectum, stomach and small bowel

·       Minimally invasive hernia repairs (incisional, ventral, inguinal)

·       Laparoscopic procedures for benign G.I. disease (appendectomy, cholecystectomy, etc.)

4. Benign G.I. & HPB Conditions

·        Complex gallstone disease and choledocholithiasis

·        Portal hypertension and variceal disease (surgical management)

·        Chronic pancreatitis with intractable pain and complications

·        Inflammatory bowel disease (IBD) requiring surgery

·        Severe reflux disease and hiatal hernia (antireflux surgery)

5. Liver Transplant & Advanced HPB Care (TrainingBacked Expertise)

While his core current practice at Shailya focuses on G.I., HPB and cancer surgery, Dr. Anand’s formal liver transplantation fellowships support nuanced decisionmaking for:

·        Transplant candidacy in liver cancer and cirrhosis

·        Pre and postoperative optimization for transplanteligible patients

·        Collaborative care with transplant centers when required

 

 

Treatment Philosophy

Dr. Kaushal Anand’s practice is built on the principles of:

·       “Clinician first, technician later” – strong emphasis on accurate diagnosis, staging and thoughtful case selection before offering surgery

·       Oncologic soundness with minimal invasiveness – marrying radical cancer clearance with laparoscopic/robotic techniques wherever safe and appropriate

·       Globalstandard protocols, local accessibility – bringing Japan and Korea–refined HPB techniques into an affordable, Indian setting

·       Patientcentric communication – explaining complex abdominal and cancer surgeries in clear, simple language to patients and families

·       Teambased care – close coordination with medical oncologists, radiologists, intensivists, anesthetists and nutritionists for best outcomes

 

Reopine Consultation Details

Through Reopine’s virtual platform, Dr. Kaushal Anand can help with:

Available Services:

·       First Opinion – Newly diagnosed G.I., liver, pancreatic, gallbladder or abdominal cancers

·       Second Opinion – Review of planned major surgery (Whipple’s, liver resection, colorectal cancer surgery, complex gallbladder, recurrent hernia, etc.)

·       HPB Focused Consults – Liver tumors, pancreatic cancer, chronic pancreatitis, bile duct strictures and choledochal cysts

·       Robotic / Laparoscopic Feasibility – Assessing whether a minimally invasive or robotic approach is safe and appropriate

·       Surgical Strategy Review – Clarifying extent of resection, staging, and sequence with chemotherapy or radiotherapy

Languages:

·       English

·       Hindi

·       Gujarati

Book Your Reopine Consultation

If you or your loved one is facing G.I., liver, pancreatic, biliary or abdominal cancer surgery, or a complex benign HPB condition, a structured opinion from a robotic G.I. and HPB specialist can be critical.

Dr. Kaushal Anand offers expert, evidencebased virtual consultations through Reopine, helping you:

·       Understand your diagnosis and staging

·       Compare open vs laparoscopic vs robotic options

·       Clarify surgical risks, benefits and alternatives

·       Decide confidently on where and how to proceed with treatment

Request your Reopine consultation to access internationalstandard G.I. and HPB surgical expertise —without leaving your home.

Yrs

Male

Female

Other

Attachment
    This is content box Two

    Date: 02 Apr 2026

    1. Nature of Services
      • I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
      • I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
    2. Teleconsultation Limitations
      • I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
      • I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
    3. Emergency Situations
      • I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
      • In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
    4. Cross-Border Consultations
      • I understand that all doctors on Reopine are licensed to practice in India only.
      • If I access the platform from outside India:
        • I agree that the consultation is deemed to have occurred in India under Indian law.
        • I accept full responsibility for compliance with my country’s local laws.
        • I waive any claim against Reopine in foreign jurisdictions.
      • The information provided during this consultation is for general health guidance and educational purposes only.
      • It is not a substitute for an in-person medical examination by a doctor licensed in your country.
      • The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
        • Consult a locally licensed physician before starting or changing any medication or treatment.
      • The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
    5. Data Privacy
      • I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
      • I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
    6. Payment, Refund & Liability
      • I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
      • I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
      • I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
    7. Consent & Acknowledgment

      By proceeding, I confirm that:

      1. I have read and understood the Terms & Conditions and this Consent Form.
      2. I voluntarily consent to teleconsultation via Reopine.
      3. I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.

    Patient’s Full Name:

    Signature: ____________________________

    Date: 02 Apr 2026

    Subcribe to our Newsletter

    Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.